Protocol Ledger

NCT04083339 · Phase III · ACTIVE NOT RECRUITING

Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy

Interventional Phase III clinical trial protocol NCT04083339 sponsored by Applied Therapeutics in Cardiovascular and Thrombosis, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2019-09-20 Enrollment: 675 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT04083339
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)675 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)3 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT04083339
Protocol FieldVerified Registry Value
NCT IdentifierNCT04083339
Consolidated Lead SponsorApplied Therapeutics
Therapeutic Condition CohortCardiovascular and Thrombosis
Clinical Trial PhasePhase III
Overall Recruitment StatusACTIVE NOT RECRUITING
Registered Enrollment675 participants (ESTIMATED)
Registered Start Date2019-09-20
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Cardiovascular and Thrombosis Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI